Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$18.8M Sell
84,802
-4,869
-5% -$1.13M 0.07% 118
2023
Q1
$21.7M Sell
89,671
-2,660
-3% -$653K 0.08% 106
2022
Q4
$24.2M Sell
92,331
-4,636
-5% -$1.24M 0.1% 105
2022
Q3
$21.9M Sell
96,967
-35,412
-27% -$8.58M 0.09% 102
2022
Q2
$32.2M Buy
132,379
+21,464
+19% +$5.26M 0.13% 86
2022
Q1
$26.8M Buy
110,915
+52,324
+89% +$12M 0.09% 91
2021
Q4
$13.2M Buy
58,591
+2,470
+4% +$521K 0.04% 146
2021
Q3
$11.9M Sell
56,121
-1,395
-2% -$321K 0.04% 150
2021
Q2
$14M Sell
57,516
-271
-0.5% -$66.7K 0.05% 140
2021
Q1
$14.4M Sell
57,787
-3,808
-6% -$909K 0.05% 129
2020
Q4
$14.2M Sell
61,595
-42,225
-41% -$9.74M 0.05% 124
2020
Q3
$26.4M Sell
103,820
-9,032
-8% -$2.24M 0.12% 74
2020
Q2
$26.6M Buy
112,852
+5,068
+5% +$1.16M 0.13% 74
2020
Q1
$21.9M Buy
107,784
+44,872
+71% +$9.8M 0.13% 75
2019
Q4
$15.2M Buy
62,912
+996
+2% +$220K 0.07% 100
2019
Q3
$12M Buy
61,916
+2,271
+4% +$436K 0.06% 107
2019
Q2
$11M Sell
59,645
-7,638
-11% -$1.37M 0.06% 110
2019
Q1
$12.8M Buy
67,283
+221
+0.3% +$42.2K 0.1% 102
2018
Q4
$13.1M Buy
67,062
+1,298
+2% +$253K 0.07% 90
2018
Q3
$13.6M Sell
65,764
-1,330
-2% -$262K 0.07% 93
2018
Q2
$12.4M Sell
67,094
-3,207
-5% -$567K 0.07% 95
2018
Q1
$12M Sell
70,301
-42,741
-38% -$7.85M 0.07% 95
2017
Q4
$19.7M Sell
113,042
-2,469
-2% -$437K 0.11% 69
2017
Q3
$21.5M Sell
115,511
-553
-0.5% -$98K 0.13% 64
2017
Q2
$20M Buy
+116,064
New +$18.9M 0.14% 64

Other funds holding AMGN

TIAA FSB's AMGN Position: Q2 2023 in Review

TIAA FSB reduced its Amgen (AMGN) stake by 5.4% in Q2 2023, selling an estimated $1.13M and leaving 84,802 shares worth $18.8M. The position accounts for 0.07% of the portfolio, ranked #118.

TIAA FSB first reported a position in AMGN in Q2 2017 and has held it in 25 quarters since. The position peaked at $32.2M in Q2 2022. 2,390 funds tracked by Wall St. Rank hold AMGN as of Q2 2023.

  • TIAA FSB held 84,802 shares of Amgen worth $18.8M as of Q2 2023.
  • TIAA FSB sold 4,869 Amgen shares in Q2 2023, an estimated $1.13M.
  • Amgen made up 0.07% of TIAA FSB's portfolio in Q2 2023, its #118 holding.
  • TIAA FSB first reported a position in Amgen in Q2 2017 and has held it in 25 quarters since.
  • TIAA FSB's Amgen position peaked at $32.2M in Q2 2022.
  • 2,390 funds tracked by Wall St. Rank held Amgen as of Q2 2023.

Based on TIAA FSB's 13F filing for Q2 2023, filed 31 Jul 2023.